Dr. Mirakhur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 Lawn Ave
Sellersville, PA 18960Phone+1 215-453-4000
Education & Training
Temple University Hospital/Chestnut Hill HospitalResidency, Family Medicine, 2001 - 2004
Lewis Katz School of Medicine at Temple UniversityClass of 2001
Certifications & Licensure
CA State Medical License 2019 - 2025
NJ State Medical License 2016 - 2023
PA State Medical License 2001 - 2021- American Board of Family Medicine Family Medicine
Clinical Trials
- Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors Start of enrollment: 2017 Apr 04
Publications & Presentations
PubMed
- 903 citationsCetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-GalactoseChristine H. Chung, Beloo Mirakhur, Emily Chan, Quynh-Thu Le, Jordan Berlin
The New England Journal of Medicine. 2008-03-13 - 32 citationsEconomic burden associated with adverse events in patients with metastatic melanoma.Bhakti Arondekar, Suellen M. Curkendall, Matthew J. Monberg, Beloo Mirakhur, Alan Oglesby
Journal of Managed Care & Specialty Pharmacy. 2015-10-16 - 30 citationsA desensitization protocol for the mAb cetuximab.Maya R. Jerath, Mildred Kwan, Mily Kannarkat, Beloo Mirakhur, Lisa A. Carey
The Journal of Allergy and Clinical Immunology. 2009-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
